Article title: A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective
Authors: Heise, M., Staubach, P., Nikolakis, G., Schollenberger, L., Mauch, M., Burckhardt, M., Zamsheva, M., Strobel, A., Langer, G., Bechara, F., Kirschner, U., Hennig, K., Kunte, C., Goebeler, M., Podda, M., Grabbe, S., & Schultheis, M.
Journal: Journal of Dermatological Treatment
Bibliometrics: Volume 34, Number 1, pages 2284105
DOI: 10.1080/09546634.2023.2284105
Firstly, in of the Cost-Effectiveness Plane, there is an error in the labeling of Quadrant IV. It should correctly read as “New Treatment is less effective and more expensive.” I have attached the corrected figure for your reference. I kindly request that this correction be acknowledged through the issuance of an Erratum. Below is the correct version of the figure:
Figure 4. Cost-effectiveness plane for AiZ-treatment in comparison to standard care.
Additionally, I have identified an error in the title of the paper. The correct title should be: “A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective” (not: cost-effectiveness).